# OnCo record pathvysion-her2 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/pathvysion-her2/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "pathvysion-her2" ;
  schema:name "PathVysion HER-2 DNA Probe Kit"@en ;
  schema:description "One of the first HER2 gene tests, approved in December 1998 to select trastuzumab for breast cancer."@en ;
  schema:url <https://onco.cc/drugs/pathvysion-her2/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P980024>, <https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "FISH companion diagnostic test (HER2 gene amplification, breast tumour tissue)" ;
  schema:alternateName "PathVysion HER-2 DNA Probe Kit" ;
  onco:approval "US 1998: HER2 gene amplification to select trastuzumab in breast cancer" ;
  onco:related <https://onco.cc/drugs/her2-testing-assays/>, <https://onco.cc/drugs/her2-fish-pharmdx/>, <https://onco.cc/biomarkers/her2-ish-amplified/> ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/>, <https://onco.cc/technologies/cytogenetics-fish/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/> ;
  onco:companies <https://onco.cc/companies/abbott/> ;
  onco:terms <https://onco.cc/terms/fish/>, <https://onco.cc/terms/her2-positive/>, <https://onco.cc/terms/companion-diagnostic-term/> .